Atrial septal defect (ASD) device trans-catheter closure: Limitations

Alessia Faccini, Gianfranco Butera

Research output: Contribution to journalReview articlepeer-review


Transcatheter closure is a widespread technique used to treat secundum atrial septal defects (ASDs). When compared to surgery, it provides a less invasive approach with quicker recovery and reduced physical and psychological impact. Nowadays, almost 85-90% of all secundum ASD can be closed by using a transcatheter approach. However, several limitations may have a significant impact on the feasibility and success of percutaneous ASD closure. Limitations can be grouped as: (I) anatomical; (II) device-related; (III) associated defects and natural history associated issues; (IV) physiological; (V) complications. Physician should be aware of potential limits of percutaneous ASD closure.

Original languageEnglish
Article numberS2923
Pages (from-to)S2923-S2930
JournalJournal of Thoracic Disease
Publication statusPublished - Sep 1 2018


  • Atrial
  • Heart septal defect
  • Interventional cardiology
  • Septal occlude device

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Atrial septal defect (ASD) device trans-catheter closure: Limitations'. Together they form a unique fingerprint.

Cite this